Céline Féger
Impact in
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus
- Clostridium difficile and Clostridium perfringens research
Papers in ⓘ
-
- Antimicrobial Resistance in Staphylococcus 8
- Clostridium difficile and Clostridium perfringens research 4
-
- Pneumonia and Respiratory Infections 3
- Microscopic Colitis 3
- Co-authors
- Roland Leclercq (4 shared papers)Michael J. Dowzicky (3 shared papers)George H. Talbot (2 shared papers)Bülent Bozdoğan (3 shared papers)Virginie Zarrouk (3 shared papers)B. Fantin (3 shared papers)Philippe Prokocimer (2 shared papers)Antoine Andremont (4 shared papers)
In The Last Decade
Céline Féger
18 papers receiving 402 citations
Peers
Comparison fields: 5 of 67
- Clinical Biochemistry 125
- Infectious Diseases 286
- Molecular Medicine 75
- Applied Microbiology and Biotechnology 26
- Critical Care and Intensive Care Medicine 27
Countries citing papers authored by Céline Féger
This map shows the geographic impact of Céline Féger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Féger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Féger more than expected).
Fields of papers citing papers by Céline Féger
This network shows the impact of papers produced by Céline Féger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Féger. The network helps show where Céline Féger may publish in the future.
Co-authors
The 25 scholars most cited alongside Céline Féger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 59 | |
| 2 | 2002 | 56 | |
| 3 | 2000 | 41 | |
| 4 | 1998 | 36 | |
| 5 | 2002 | 35 | |
| 6 | 2000 | 34 | |
| 7 | 2001 | 27 | |
| 8 | 2021 | 26 | |
| 9 | 2021 | 25 | |
| 10 | 2021 | 20 | |
| 11 | 1999 | 18 | |
| 12 | 2011 | 16 | |
| 13 | 2000 | 15 | |
| 14 | 2006 | 11 | |
| 15 | 2021 | 2 | |
| 16 | 2020 | 2 | |
| 17 | 2001 | 1 | |
| 18 | 2022 | 1 |
About Céline Féger
Céline Féger is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Clinical Biochemistry and Pharmacology, having authored 18 papers that have together received 425 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (8 papers), Bacterial Identification and Susceptibility Testing (5 papers), Clostridium difficile and Clostridium perfringens research (4 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Pneumonia and Respiratory Infections (3 papers), Microscopic Colitis (3 papers), Bacterial biofilms and quorum sensing (2 papers) and Emergency and Acute Care Studies (2 papers). The work is most often cited by research in Clinical Biochemistry (125 citations), Infectious Diseases (286 citations), Molecular Medicine (75 citations), Applied Microbiology and Biotechnology (26 citations) and Critical Care and Intensive Care Medicine (27 citations). Céline Féger has collaborated with scholars based in France, Canada and Germany. Frequent co-authors include Roland Leclercq, Michael J. Dowzicky, George H. Talbot, Bülent Bozdoğan, Virginie Zarrouk, B. Fantin, Philippe Prokocimer, Antoine Andremont, Annie Ducher and Jean de Gunzburg. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Critical Care, Diagnostic Microbiology and Infectious Disease, Clinical Microbiology and Infection and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.